Clinical Scorecard: Worldwide Impact of Colorectal Cancer in 2022 and Forecasts for 2050: Incidence and Mortality Data from GLOBOCAN
At a Glance
Category
Detail
Condition
Colorectal Cancer (CRC)
Key Mechanisms
Varies by stage and molecular subtype; influenced by both non-modifiable (hereditary syndromes, chronic inflammatory conditions) and modifiable risk factors (lifestyle choices).
Target Population
Global population, with increasing incidence in individuals under 50 years.
Care Setting
Multimodal treatment settings including screening, surgery, and targeted therapies.
Key Highlights
CRC is the second leading cause of cancer-related mortality worldwide.
Significant rise in CRC incidence among individuals under 50 years.
GLOBOCAN provides standardized cancer incidence and mortality estimates.
Current CRC prevention strategies face misalignments with population aging and resource allocation.
The study aims to refine CRC prevention and control strategies globally.
Guideline-Based Recommendations
Diagnosis
Utilize GLOBOCAN data for updated incidence and mortality estimates.
Management
Implement comprehensive multimodal treatment including screening and targeted therapies.
Monitoring & Follow-up
Regularly update risk prediction models based on changing exposure patterns.
Risks
Address both hereditary and lifestyle-related risk factors for CRC.
Patient & Prescribing Data
Individuals at risk for CRC, particularly those with hereditary syndromes or high-risk lifestyle factors.
